IL-3 and TNFα increase Thymic Stromal Lymphopoietin Receptor (TSLPR) expression on eosinophils and enhance TSLP-stimulated degranulation

Clinical and Molecular Allergy

Volumn 10, Issue , 2012, Pages

  Cook, Ellen B ^a   Stahl, James L ^a   Schwantes, Elizabeth A ^a   Fox, Kristen E ^a   Mathur, Sameer K ^a,b  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b WILLIAM S MIDDLETON MEMORIAL VETERANS HOSPITAL   (United States)

Author keywords

Allergic inflammation; Eosinophil derived neurotoxin; Eosinophils; Thymic stromal lymphopoietin

Indexed keywords

CELL PROTEIN; INTERLEUKIN 3; INTERLEUKIN 5; INTERLEUKIN 7 RECEPTOR ALPHA; MESSENGER RNA; NEUROTOXIN; STAT5 PROTEIN; THYMIC STROMAL LYMPHOPOIETIN RECEPTOR; TRYPAN BLUE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; CELL ACTIVATION; CELL FUNCTION; CELL STIMULATION; CELL SURVIVAL; CELL VIABILITY; CHEMOTAXIS; DEGRANULATION; EOSINOPHIL; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UPREGULATION;

EID: 84864225481     PISSN: None     EISSN: 14767961     Source Type: Journal    
DOI: 10.1186/1476-7961-10-8     Document Type: Article

References (26)

1. Holgate ST. The epithelium takes centre stage in asthma and atopic dermatitis. Trends Immunol 2007, 28:248-251. 10.1016/j.it.2007.04.007, 17466594.
2. Rochman Y, Leonard WJ. Thymic stromal lymphopoietin: a new cytokine in asthma. Curr Opin Pharmacol 2008, 8:249-254. 10.1016/j.coph.2008.03.002, 2518061, 18450510.
3. Mou Z, Xia J, Tan Y, Wang X, Zhang Y, Zhou B, Li H, Han D. Overexpression of thymic stromal lymphopoietin in allergic rhinitis. Acta Otolaryngol 2009, 129:297-301. 10.1080/00016480802225884, 18720075.
4. Kimura S, Pawankar R, Mori S, Nonaka M, Masuno S, Yagi T, Okubo K. Increased expression and role of thymic stromal lymphopoietin in nasal polyposis. Allergy Asthma Immunol Res 2011, 3:186-193. 10.4168/aair.2011.3.3.186, 3121060, 21738884.
5. Matsuda A, Ebihara N, Yokoi N, Kawasaki S, Tanioka H, Inatomi T, de Waal MR, Hamuro J, Kinoshita S, Murakami A. Functional role of thymic stromal lymphopoietin in chronic allergic keratoconjunctivitis. Invest Ophthalmol Vis Sci 2010, 51:151-155. 10.1167/iovs.09-4183, 19741251.
6. Roan F, Bell BD, Stoklasek TA, Kitajima M, Han H, Ziegler SF. The multiple facets of thymic stromal lymphopoietin (TSLP) during allergic inflammation and beyond. J Leukoc Biol 2012, 91:877-886. 10.1189/jlb.1211622, 22442496.
7. Soumelis V, Reche PA, Kanzler H, Yuan W, Edward G, Homey B, Gilliet M, Ho S, Antonenko S, Lauerma A, Smith K, Gorman D, Zurawski S, Abrams J, Menon S, McClanahan T, Waal-Malefyt R, Bazan F, Kastelein RA, Liu YJ. Human epithelial cells trigger dendritic cell-mediated allergic inflammation by producing TSLP. Nat Immunol 2002, 3:673-680. 10.1038/nrm910, 12055625.
8. Ito T, Wang YH, Duramad O, Hori T, Delespesse GJ, Watanabe N, Qin FXF, Yao ZB, Cao W, Liu YJ. TSLP-activated dendritic cells induce an inflammatory T helper type 2 cell response through OX40 ligand. J Exp Med 2005, 202:1213-1223. 10.1084/jem.20051135, 2213234, 16275760.
9. Rochman I, Watanabe N, Arima K, Liu YJ, Leonard WJ. Cutting edge: direct action of thymic stromal lymphopoietin on activated human CD4(+) T cells. J Immunol 2007, 178:6720-6724.
10. Allakhverdi Z, Comeau MR, Jessup HK, Yoon BRP, Brewer A, Chartier S, Paquette N, Ziegler SF, Sarfati M, Delespesse G. Thymic stromal lymphopoietin is released by human epithelial cells in response to microbes, trauma, or inflammation and potently activates mast cells. J Exp Med 2007, 204:253-258. 10.1084/jem.20062211, 2118732, 17242164.
11. Wong CK, Hu S, Cheung PFY, Lam CW. TSLP induces chemotactic and pro-survival effects in eosinophils: implications in allergic inflammation. Am J Respir Cell Mol Biol 2010, 43:305-315. 10.1165/rcmb.2009-0168OC, 19843704.
12. Ziegler SF. The role of thymic stromal lymphopoietin (TSLP) in allergic disorders. Curr Opin Immunol 2010, 22:795-799. 10.1016/j.coi.2010.10.020, 3032269, 21109412.
13. Reefer AJ, Hulse KE, Lannigan JA, Solga MD, Wright PW, Kelly LA, Patrie J, Chapman MD, Woodfolk JA. Flow cytometry imaging identifies rare T(H)2 cells expressing thymic stromal lymphopoietin receptor in a " proallergic" milieu. J Allergy Clin Immunol 2010, 126:1049-1058. 1058, 10.1016/j.jaci.2010.07.023, 3034251, 20888036.
14. Hogan SP, Rosenberg HF, Moqbel R, Phipps S, Foster PS, Lacy P, Kay AB, Rothenberg ME. Eosinophils: biological properties and role in health and disease. Clin Exp Allergy 2008, 38:709-750. 10.1111/j.1365-2222.2008.02958.x, 18384431.
15. Kelly EAB, Koziol-White CJ, Clay KJ, Liu LY, Bates ME, Bertics PJ, Jarjour NN. Potential contribution of IL-7 to allergen-induced eosinophilic airway inflammation in asthma. J Immunol 2009, 182:1404-1410. 2851244, 19155487.
16. Cook EB, Stahl JL, Sedgwick JB, Barney NP, Graziano FM. The promotion of eosinophil degranulation and adhesion to conjunctival epithelial cells by IgE-activated conjunctival mast cells. Ann Allergy Asthma Immunol 2004, 92:65-72. 10.1016/S1081-1206(10)61712-7, 14756467.
17. Sedgwick JB, Calhoun WJ, Vrtis RF, Bates ME, Mcallister PK, Busse WW. Comparison of airway and blood eosinophil function after invivo antigen challenge. J Immunol 1992, 149:3710-3718.
18. Sedgwick JB, Vrtis RF, Gourley MF, Busse WW. Stimulus-dependent differences in superoxide anion generation by normal human eosinophils and neutrophils. J Allergy Clin Immunol 1988, 81:876-883. 10.1016/0091-6749(88)90945-1, 2836491.
19. Sedgwick JB, Hwang YS, Gerbyshak HA, Kita H, Busse WW. Oxidized low-density lipoprotein activates migration and degranulation of human granulocytes. Am J Respir Cell Mol Biol 2003, 29:702-709. 10.1165/rcmb.2002-0257OC, 12777245.
20. Stout BA, Bates ME, Liu LY, Farrington NN, Bertics PJ. IL-5 and granulocyte-macrophage colony-stimulating factor activate STAT3 and STAT5 and promote pim-1 and cyclin D3 protein expression in human eosinophils. J Immunol 2004, 173:6409-6417.
21. Rothenberg ME, Owen WF, Silberstein DS, Woods J, Soberman RJ, Austen KF, Stevens RL. Human eosinophils have prolonged survival, enhanced functional properties, and become hypodense when exposed to human interleukin 3. J Clin Invest 1988, 81:1986-1992. 10.1172/JCI113547, 442652, 3133397.
22. Zhu Y, Bertics PJ. Chemoattractant-induced signaling via the Ras-ERK and PI3K-Akt networks, along with leukotriene C4 release, is dependent on the tyrosine kinase Lyn in IL-5- and IL-3-primed human blood eosinophils. J Immunol 2011, 186:516-526. 10.4049/jimmunol.1000955, 3156584, 21106848.
23. Luijk B, Lindemans CA, Kanters D, van der HR, Bertics P, Lammers JW, Bates ME, Koenderman L. Gradual increase in priming of human eosinophils during extravasation from peripheral blood to the airways in response to allergen challenge. J Allergy Clin Immunol 2005, 115:997-1003. 10.1016/j.jaci.2005.02.002, 15867857.
24. Sedgwick JB, Vrtis RF, Jansen KJ, Kita H, Bartemes K, Busse WW. Peripheral blood eosinophils from patients with allergic asthma contain increased intracellular eosinophil-derived neurotoxin. J Allergy Clin Immunol 2004, 114:568-574. 10.1016/j.jaci.2004.05.023, 15356558.
25. Jessup HK, Brewer AW, Omori M, Rickel EA, Budelsky AL, Yoon BRP, Ziegler SF, Comeau MR. Intradermal administration of thymic stromal lymphopoietin induces a T cell- and eosinophil-dependent systemic Th2 inflammatory response. J Immunol 2008, 181:4311-4319.
26. Demehri S, Morimoto M, Holtzman MJ, Kopan R. Skin-derived TSLP triggers progression from epidermal-barrier defects to asthma. Plos Biology 2009, 7(85):E1000067. 10.1371/journal.pbio.1000067, 2700555, 19557146.